InsidersTradesSigma
씨엑스아이 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 씨엑스아이 stock price and the full insider trade history of the company, a publicly traded company based in South Korea. Shares are quoted on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 씨엑스아이 has recorded 49 reports. Market capitalisation: €30.7bn. The latest transaction was filed on 16 July 2026 (Purchase). Among the most active insiders: LIN JINSHENG. Every trade is openly available.
48
Insider Decl.
n/a
Thresholds
n/a
23 ops.
Buy Volume
n/a
5 ops.
Sell Volume
6Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 385 of 28,065 companies
85.9
score / 100
Value100
Quality72
FCF yld·
Earn yld98%
EV/EBITDA0.6x
ROE1.6%
Gross mgn43%
Net mgn42%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 July 2026
Declarations49 total
Other
Other(filed)
1,700,000 sharesShareKRXDART:20260716000366
1,700,000 sharesKRXDART:20260716000363
2,513,972 sharesKRXDART:20260316000488
25,000,000 sharesKRXDART:20260312001274
6,776,547 sharesKRXDART:20260312001139
37,060,509 sharesKRXDART:20250825000363
ShareKRXDART:20241125000281
15,000,000 sharesKRXDART:20241125000268
ShareKRXDART:20241125000272
0KRXDART:20241125000273
25,000,000 sharesKRXDART:20241031000416
ShareKRXDART:20241018000499
25,000,000 sharesKRXDART:20231205000391
25,000,000 sharesKRXDART:20231128000946
25,000,000 sharesKRXDART:20231128000934
25,000,000 sharesKRXDART:20230710000455
25 of 49 declarations
About 씨엑스아이
씨엑스아이 is a healthcare and pharmaceutical company listed on the XKRX market. It specializes in the development and commercialization of pharmaceutical products.